A carregar...
CCL5 as a potential immunotherapeutic target in triple-negative breast cancer
Breast cancer (BC) is a leading cause of mortality among women in the world. To date, a number of molecules have been established as disease status indicators and therapeutic targets. The best known among them are estrogen receptor-α (ER-α), progesterone receptor (PR) and HER-2/neu. About 15%–20% BC...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4003203/ https://ncbi.nlm.nih.gov/pubmed/23376885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cmi.2012.69 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|